company background image
STSS logo

Sharps Technology NasdaqCM:STSS Stock Report

Last Price

US$0.35

Market Cap

US$5.3m

7D

10.9%

1Y

-71.8%

Updated

25 Feb, 2024

Data

Company Financials +

Sharps Technology, Inc.

NasdaqCM:STSS Stock Report

Market Cap: US$5.3m

STSS Stock Overview

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States.

STSS fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Sharps Technology, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sharps Technology
Historical stock prices
Current Share PriceUS$0.35
52 Week HighUS$1.58
52 Week LowUS$0.27
Beta0
1 Month Change6.42%
3 Month Change-23.26%
1 Year Change-71.77%
3 Year Changen/a
5 Year Changen/a
Change since IPO-83.41%

Recent News & Updates

Recent updates

Shareholder Returns

STSSUS Medical EquipmentUS Market
7D10.9%2.2%1.3%
1Y-71.8%14.0%25.6%

Return vs Industry: STSS underperformed the US Medical Equipment industry which returned 14% over the past year.

Return vs Market: STSS underperformed the US Market which returned 25.6% over the past year.

Price Volatility

Is STSS's price volatile compared to industry and market?
STSS volatility
STSS Average Weekly Movement12.5%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: STSS's share price has been volatile over the past 3 months.

Volatility Over Time: STSS's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
201758Robert Hayeshttps://sharpstechnology.com

Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.

Sharps Technology, Inc. Fundamentals Summary

How do Sharps Technology's earnings and revenue compare to its market cap?
STSS fundamental statistics
Market capUS$5.35m
Earnings (TTM)-US$7.59m
Revenue (TTM)n/a

0.0x

P/S Ratio

-0.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
STSS income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$7.59m
Earnings-US$7.59m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.50
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did STSS perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.